Idiopathic Intracranial Hypertension (IIH)

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Hydrostatic and Mechanical Insult: Idiopathic Intracranial Hypertension (IIH), historically termed pseudotumor cerebri, is a disorder characterized by chronically elevated Intracranial Pressure (ICP) with corresponding mechanical symptoms, but with completely normal Cerebrospinal Fluid (CSF) constituents and no neuroimaging evidence of space-occupying lesions or venous sinus thrombosis. While the precise underlying mechanism is not fully understood, it is classically attributed to an active hydrostatic imbalance between CSF production and reabsorption pathways.
• Optic Nerve Compression and Visual Loss: The persistent elevation of CSF hydrostatic pressure within the subarachnoid space surrounding the optic nerve directly deforms and compresses the nerve sheath. This mechanical pressure blocks axoplasmic flow, manifesting as papilledema (the clinical hallmark of IIH, which is typically bilateral and symmetric, though unilateral cases can occur in a small percentage of patients). Chronic compression leads to progressive axonal loss; notably, visual field loss occurs before the loss of visual acuity. High-grade papilledema, graded and standardized using the Frisen Scale, is strongly associated with severe, permanent vision loss.
• Cranial Nerve VI Stretch Injury: Because the abducens nerve (CN VI) has the longest course in the subarachnoid space and is exceptionally thin, it is highly vulnerable to mechanical stretch injury under elevated ICP. Compression of CN VI causes lateral rectus palsy (seen in 10% to 20% of patients), which drives horizontal diplopia and nasal deviation of the affected eye (esotropia). Importantly, sensory deficits and other focal signs (such as dysmetria, apraxia, or reflex abnormalities) are characteristically absent, signifying a benign neurological examination outside of isolated CN VI palsy.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Primary Bedside Stabilization: IIH is strictly a diagnosis of exclusion. If clinical suspicion exists for alternative, life-threatening causes of elevated ICP (such as a massive intracranial hemorrhage, space-occupying lesion, or venous sinus thrombosis), resuscitation must prioritize airway protection, maintaining strict normocapnia, and avoiding hypotension to preserve cerebral perfusion pressure.
• Immediate Action for Ocular Emergencies (Fulminant IIH):
• Identify patients presenting with rapidly progressive vision loss (fulminant IIH), which represents an absolute ophthalmic emergency.
• Consult ophthalmology immediately to consider urgent optic nerve sheath fenestration.
• If ophthalmology is unavailable, consult neurosurgery immediately to evaluate for urgent CSF diversion via ventriculoperitoneal or lumboperitoneal shunting.
• Stepwise Medical Therapy:
• Acetazolamide (First-Line): Initiate 250 to 500 mg orally twice daily in patients presenting with moderate papilledema or any symptoms of visual impairment. In consultation with neurology, titrate this dose progressively based on symptom resolution up to a maximum of 2,000 mg per day.
• Topiramate (Refractory/Intolerant Alternative): For patients who cannot tolerate acetazolamide, topiramate (an antiseizure medication that inhibits carbonic anhydrase) can be initiated at 25 mg orally once daily, titrated up to 100 mg every 12 hours.
• Furosemide (Adjunctive): Furosemide can be used as an alternative or adjunctive therapy in conjunction with acetazolamide for refractory symptoms, started at 20 mg orally once daily and titrated up to 40 mg twice daily (though routine evidence supporting its use is limited).
• Procedural CSF Drainage: Perform a therapeutic lumbar puncture (LP) to alleviate severe headaches. Drain 20 to 30 mL of CSF, meticulously recording both the opening and closing pressures.
• Supportive Lifestyle & Pain Controls:
• Manage active headaches with typical migraine treatment protocols tailored to the patient’s clinical status (e.g., accounting for pregnancy-related medication restrictions or allergies).
• Counsel patients with obesity on weight-loss, salt-restriction, and fluid-restriction regimens to improve symptoms and minimize recurrence.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

Top Critical "Can't-Miss" Differential Diagnoses (IIH Mimics)

1. Cerebral Venous Thrombosis (CVT): Highly critical mimic that presents with progressive headache, papilledema, and CN VI palsy. Distinguish CVT by a history of syncopal episodes, rapid/profound vision loss, seizures, or focal deficits that do not align with a single arterial distribution.
2. Aneurysmal Subarachnoid Hemorrhage (aSAH): Presents with an abrupt, instantly peaking "thunderclap" headache, neck pain or stiffness, and a decreased level of consciousness.
3. Intracranial Space-Occupying Lesion (Tumor, Abscess, or Hematoma): Elevated ICP secondary to mass effect; distinguished by focal motor/sensory deficits, fever, localized cranial tenderness, or history of trauma.
4. Acute Hydrocephalus: Characterized by ventricular enlargement; presents with progressive cognitive decline, vomiting, and prominent gait ataxia.
5. Meningitis or Encephalitis: Differentiated by acute fever, prominent meningismus, and pleocytosis on CSF analysis.
6. Severe Preeclampsia or Eclampsia: Occurs in patients >20 weeks pregnant or up to 8 weeks postpartum; presents with severe headache, visual scotomata, proteinuria, and systemic edema.

Prioritized Diagnostic Workup Strategy

• Bedside Glucose Check: Perform a fingerstick glucose immediately on arrival to rule out hypoglycemia or diabetic ketoacidosis.
• Blood Pressure Screening: Rapidly assess blood pressure to exclude malignant hypertension (>180/120 mm Hg) as the cause of headache and papilledema.
• Meticulous Ocular Assessment: Document visual acuity (the vital sign of the eye), perform a formal bedside visual field assessment (crucial because visual fields fail before acuity), and evaluate extraocular movements (CN VI check).
• Urgent Brain and Vascular Neuroimaging: Order a brain MRI with contrast and Magnetic Resonance Venography (MRV) to rule out space-occupying lesions, meningeal processes, and venous sinus thrombosis. If MRI is unavailable, obtain a brain CT with CT Venography (CTV). Board Pearl: Venography of the cerebral venous system is an essential part of the workup to exclude CVT as the cause of papilledema.
• Diagnostic Lumbar Puncture: Perform an LP only after neuroimaging has successfully excluded space-occupying masses or venous thrombosis to prevent brain herniation. The LP must be performed in the left lateral decubitus position with the patient's legs relaxed to ensure an accurate opening pressure. Send CSF for glucose, protein, cell count, and cultures (all of which must be completely normal).

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

12-Lead ECG Checklist

• Check for normal sinus rhythm and rate. Ensure there are no ischemic changes, prolonged QT intervals, or tachy/bradyarrhythmias. The ECG is expected to be normal in uncomplicated IIH, helping rule out systemic perfusion failure or secondary hypertensive cardiac damage.

Point-of-Care Ultrasound (POCUS) Checklist

• Optic Nerve Sheath Diameter (ONSD): Utilize ocular POCUS as an adjunctive bedside tool to measure ONSD; a diameter >5 mm is suggestive of elevated ICP.
• Board Warning: Residents must explicitly state that ONSD findings should be used with caution, as recent literature disputes the diagnostic accuracy of sonographic nerve sheath measurements.

Neuroimaging Diagnostic Checklist (CT / MRI / Venography)

• Verify the complete absence of space-occupying lesions, mass effect, midline shift, abnormal meningeal enhancement, or venous filling defects.
• Evaluate for classic neuroimaging features suggestive of chronically increased ICP (though their absence does not exclude IIH):

    1.  **Empty sella** (flattening of the pituitary gland).
    2.  **Enlarged optic nerve sheath**.
    3.  **Tortuosity of the optic nerve**.
    4.  **Flattened posterior globe**.

Lumbar Puncture Diagnostic Metric

• ** opening pressure:** Confirm and document a CSF opening pressure of >=25 cm H2O on an LP performed in the left lateral decubitus position to meet diagnostic criteria.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

Risk Stratification and Epidemiological Matrix

• Demographic Profile: IIH carries an overall incidence of 1 in 100,000, which rises significantly to 3.5 in 100,000 in females of childbearing age (15 to 44 years).
• Obesity Correlation: The diagnosis occurs 10 times more often in women than in men, with the risk compounding dramatically with obesity and the rising BMI epidemic.
• Medication Exposure Risk: Review the patient's medication list for highly associated risk-modulators: oral contraceptives, tetracyclines, fluoroquinolones, vitamin A supplements, isotretinoin, and lithium.

Definite IIH Diagnostic Criteria

To formally establish a diagnosis of IIH in the ED, the patient must fulfill the following criteria:

1. Elevated Opening Pressure: Documented CSF opening pressure of >=25 cm H2O measured in the left lateral decubitus position with relaxed legs.
2. Papilledema: Symmetrical or occasionally unilateral papilledema present on funduscopic exam.
3. Normal CSF Analysis: Normal glucose, protein, cell count, and negative cultures.
4. Normal Neuroimaging: MRI/MRV (or CT/CTV) demonstrating the complete absence of space-occupying lesions, meningeal processes, or venous sinus thrombosis.
5. Exclusion of Alternate Causes: Absence of other identifiable etiologies of increased ICP.

Papilledema Severity Matrix

• The Frisen Scale: The standardized grading scale utilized by ophthalmology and emergency providers to classify papilledema severity and dictate the urgency of sight-saving medical or surgical interventions.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

Deadly Cognitive Traps & Trainee Pitfalls

• The "Migraine" Premature Closure: Dismissing a patient's progressive headache as a standard "migraine" because it is bilateral, pulsating, and accompanied by nausea, while failing to perform a visual acuity or fundoscopic exam to evaluate for papilledema.
• The Sitting LP Opening Pressure Error: Obtaining the CSF opening pressure with the patient in a sitting position or with their legs tightly flexed. This artifactually elevates the pressure, resulting in false-positive diagnoses and invalidating the diagnostic >=25 cm H2O cutoff.
• The "Normal Head CT" Diagnostic Trap: Discharging a patient with headache and papilledema because their non-contrast head CT is normal. A standard non-contrast head CT cannot exclude Cerebral Venous Thrombosis (CVT); contrast-enhanced venous system imaging (MRV or CTV) is mandatory to rule out this life-threatening mimic.
• The Valsalva opening pressure trap: Failing to recognize that patient pain, crying, or anxiety-induced Valsalva maneuvers can transiently spike the opening pressure, necessitating the use of anxiolytics on an individual basis to obtain an accurate reading.

Mandated Board-Exam Critical Actions

• Perform and document a fundoscopic exam (or use a nonmydriatic digital fundus camera) on any patient presenting with new, worsening, or atypical headaches.
• Formally measure and document visual acuity and visual fields in the ED, recognizing that visual field loss precedes visual acuity impairment in IIH.
• Order contrast-enhanced brain venography (MRV or CTV) as an essential component of the initial neuroimaging workup to exclude venous sinus thrombosis.
• Meticulously perform the diagnostic lumbar puncture in the left lateral decubitus position with relaxed legs, documenting both the opening and closing pressures.
• Identify and aggressively treat rapidly progressive vision loss (fulminant IIH) as a surgical emergency, immediately consulting ophthalmology for optic nerve sheath fenestration or neurosurgery for CSF shunting.

7. MCQ MASTERCLASS (Written Exam Tips)

High-Yield Exam "Buzzwords" and Associations

• "Empty sella, flattened posterior globe, and optic nerve sheath enlargement" are the classic radiographic features of chronically elevated ICP on MRI.
• "Unilateral or bilateral sixth nerve palsy (lateral rectus palsy)" is the only acceptable focal neurological sign in uncomplicated IIH; any other focal neurological deficit points to a stroke or mass lesion.
• "Opening pressure >=25 cm H2O with normal CSF chemistry" is the pathognomonic diagnostic standard.
• "Frisen Scale" is the standardized grading scale for papilledema.
• "Headache worse on awakening, exacerbated by bending forward or the Valsalva maneuver" represents the classic clinical description.

Differentiating Distractors

• Distractor: Initiating high-dose intravenous corticosteroids (such as Methylprednisolone 1,000 mg IV) for suspected IIH with vision loss.
• Correction: Corticosteroids are contraindicated for ICP elevation in intracranial hemorrhage or mass lesions, and are not the first-line medical therapy for IIH. Acetazolamide is the absolute first-line medical therapy; steroids are reserved for optic neuritis or temporal arteritis.
• Distractor: Recommending an immediate lumbar puncture as the first diagnostic step in a patient with headache and papilledema.
• Correction: Neuroimaging (MRI or CT) must always be obtained before performing an LP to exclude a space-occupying lesion or venous sinus thrombosis, which prevents catastrophic brain herniation during the procedure.
• Distractor: Initiating daily meclizine for IIH-associated dizziness.
• Correction: Meclizine is indicated for peripheral vestibular disorders (like Ménière's) but is ineffective for IIH; dizziness in IIH is a central pressure symptom managed by lowering ICP with acetazolamide.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

Triage and Stabilization Script

• "This patient is a 30-year-old obese female presenting with a progressive, severe headache that is worse on awakening, accompanied by transient visual obscurations and lateral rectus palsy. Because these signs indicate severely elevated intracranial pressure, I will place the patient in a monitored resuscitation bay, establish intravenous access, and immediately check a point-of-care capillary glucose to rule out hypoglycemia. If she has any signs of impending airway or respiratory compromise, I will stabilize the airway, maintain strict normocapnia, and diligently avoid hypotension to preserve cerebral perfusion pressure.".

Mandatory Physical Exam Phrasing

• "I will perform a comprehensive neurological and ocular examination. I will explicitly measure and document visual acuity and perform a formal visual field assessment, noting that visual field loss occurs before visual acuity loss in IIH. I will perform a detailed fundoscopic exam to evaluate for bilateral, symmetric papilledema, and grade its severity using the Frisen Scale. I will meticulously test cranial nerves, checking for lateral rectus palsy indicative of a sixth nerve palsy, and confirm that there are no other focal deficits, as the rest of the neurological exam must be normal.".

Diagnostics and Management Phrasing

• "Because IIH is a diagnosis of exclusion, I will first order brain imaging to rule out dangerous secondary causes of elevated ICP. I prioritize an MRI of the brain with contrast and an MRV. If MRI is unavailable, I will order a CT scan of the brain with CT venography, recognizing that venography is an essential step to exclude cerebral venous thrombosis. If the imaging is negative for mass lesions or thrombosis, I will perform a diagnostic and therapeutic lumbar puncture in the left lateral decubitus position with the patient's legs relaxed. I will measure and record the opening pressure, expecting a pressure >=25 cm H2O. I will send CSF for glucose, protein, cell count, and cultures.".
• "If she has rapidly progressive vision loss, representing fulminant IIH, I will immediately consult ophthalmology for urgent optic nerve sheath fenestration, or neurosurgery for CSF shunting. For moderate papilledema or mild visual symptoms, I will initiate Acetazolamide 250 to 500 mg orally twice daily, titrated up to a maximum of 2,000 mg per day. If they are intolerant, I will initiate Topiramate 25 mg daily. I will perform a therapeutic LP draining 20 to 30 mL of CSF for immediate pain relief, and record a closing pressure.".

Disposition Phrasing

• "I will admit patients with significant or progressing vision loss, or those with severe, refractory headaches that cannot be controlled in the ED, for inpatient medical management and potential surgical intervention. Patients with mild symptoms and no sustained vision loss can be safely discharged home on oral acetazolamide with close, secured outpatient follow-up with neurology and ophthalmology within a defined period, along with counseling on lifestyle modifications and weight loss.".